Literature DB >> 16148332

The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisis.

Kara Zivin Bambauer1, James E Sabin, Stephen B Soumerai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148332     DOI: 10.1176/appi.ps.56.9.1143

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  12 in total

1.  Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.

Authors:  Michael K Ong; Haiyong Xu; Lily Zhang; Francisca Azocar; Susan L Ettner
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

2.  Preparing for a benzodiazepine tsunami.

Authors:  Deepak Prabhakar
Journal:  Psychiatry (Edgmont)       Date:  2009-11

3.  Medicare part d and the federal employees health benefits program: a comparison of prescription drug coverage.

Authors:  Annesha Lovett
Journal:  Am Health Drug Benefits       Date:  2013-01

4.  Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.

Authors:  Jeanne M Madden; Alyce S Adams; Robert F LeCates; Dennis Ross-Degnan; Fang Zhang; Haiden A Huskamp; Daniel M Gilden; Stephen B Soumerai
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

5.  Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.

Authors:  Becky A Briesacher; Stephen B Soumerai; Terry S Field; Hassan Fouayzi; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2010-04-26

6.  Reimbursement restriction and moderate decrease in benzodiazepine use in general practice.

Authors:  Joëlle M Hoebert; Patrick C Souverein; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Liset van Dijk
Journal:  Ann Fam Med       Date:  2012 Jan-Feb       Impact factor: 5.166

7.  Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.

Authors:  Michael K Ong; Lily Zhang; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2012-07       Impact factor: 3.084

8.  Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.

Authors:  Hui-wen Keri Yang; Linda Simoni-Wastila; Ilene H Zuckerman; Bruce Stuart
Journal:  Psychiatr Serv       Date:  2008-04       Impact factor: 3.084

9.  Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study.

Authors:  Joan M Cook; Randall Marshall; Christina Masci; James C Coyne
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

10.  Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.

Authors:  Christine Leopold; Fang Zhang; Aukje K Mantel-Teeuwisse; Sabine Vogler; Silvia Valkova; Dennis Ross-Degnan; Anita K Wagner
Journal:  Int J Equity Health       Date:  2014-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.